We are live on ! Find out more
HURA

TuHURA Biosciences

7 hedge funds and large institutions have $1.3M invested in TuHURA Biosciences in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 77 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

57% less capital invested

Capital invested by funds: $3.06M → $1.3M (-$1.76M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

HURA Hedge Fund Activity: Q4 2017 in Review

7 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2017, worth a combined $1.3M — down 57% from $3.06M a quarter earlier.

Fund positioning in HURA was balanced in Q4 2017: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Creative Planning, opening a new position worth an estimated $31K. The largest seller was Sabby Management, exiting entirely with an estimated $1.78M sold.

  • 7 institutional investors held TuHURA Biosciences (HURA) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $1.3M of TuHURA Biosciences stock for Q4 2017, down 57% quarter-over-quarter.
  • 3 funds opened new TuHURA Biosciences positions in Q4 2017 and 3 closed out, a net change of 0 holders.
  • The largest TuHURA Biosciences buyer in Q4 2017 was Creative Planning, an estimated $31K added.
  • The largest TuHURA Biosciences seller in Q4 2017 was Sabby Management, an estimated $1.78M sold.

Based on aggregated 13F filings for Q4 2017.